Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 12,156 shares at $10.58 ($129K) on 2025-02-21, disclosed to the SEC on 2025-02-25.
Open-market sale of $129k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.58 | 6,078 | $64K | 50.0% |
| 2 | $10.58 | 6,078 | $64K | 50.0% |
| Total | $10.58 avg | 12,156 | $129K | 100% |
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |
| RCKT | SELL | 2024-08-20 | $148K | — | Filing → |